Thailand became the first South East Asian country to allow the use of cannabis oil in medical trials. The country is expected to start state-sanctioned clinical trials testing the impact of cannabis oil on selected patients in July, this year.
Government Pharmaceutical Organisation (GPO), Thailand is expected to allow administration of extracts or "sublingual drops" on volunteers suffering from nausea and pain from chemotherapy, among other ailments during the trials.
The cannabis oil is supposed to be extracted from a government-managed indoor plantation that opened recently in the outskirts of Bangkok. The facility has approximately 140 plants that are cultivated under controlled lighting, temperatures and a misting system known as aeroponics.
Medical cannabis is gaining acceptance worldwide and several countries have legalized medicinal cannabis, including Canada, Australia, Israel, and more than half the states in the US. The global market for medical marijuana could reach about $55.8 billion by 2025, according to Grand View Research.
Medical cannabis will be addressed at CMT’s CannaBiz Invest Asia on 29-30 August, 2019 in Bangkok.
